Daratumumab–lenalidomide and the immunosuppressive budget in myeloma – Authors' reply

The Lancet Oncology 2026

View at publisher

Authors: Salomon Manier, Jérôme Lambert, Cyrille Hulin, Margaret Macro, Xavier P Leleu, Thierry T.F. Facon

DOI: 10.1016/s1470-2045(26)00019-7

Cited by: 0

References: 1

Fields of Study & Subjects

Multiple Myeloma Research and Treatments Health Systems Economic Evaluations Quality of Life Economic and Financial Impacts of Cancer

References 1